八月 2026
- Home
- Accord Healthcare
八月 2026的Accord Healthcare市场份额分析
Accord Healthcare(包含公司地区分支机构)
查看更多网站流量和参与度信息- accord-healthcare.com
Accord Healthcare收入截至 八月 2026为 500M - 1B
Accord Healthcare主要域名产生的收入
3 年中Accord Healthcare主要域名的收入
Accord Healthcare主要域名的收入
Accord Healthcare热门域名的总访问量
了解Accord Healthcare市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Accord Healthcare热门域名的平均访问时长
分析Accord Healthcare参与度指标。
过去 3 个月的平均访问时长
子公司明细
Accord Healthcare热门域名的平均页面浏览量
了解Accord Healthcare如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Accord Healthcare 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Novartis AG identified as competitor of Accord Healthcare on Aug 13th '26.LONDON, Aug 13 (Reuters) - Swiss drugmaker Novartis on Thursday defeated a bid to invalidate its patent for blockbuster heart drug Entresto, with London's High Court rejecting a claim by Intas Pharmaceuticals' Accord Healthcare which was planning a generic rival.
八月 13, 2026阅读更多
新闻Johnson & Johnson files suit against Accord Healthcare, Ltd..The challenged patents were previously asserted by Janssen against Accord and Bio-Thera in pending litigation in the District of Delaware, No. 1:26-cv-00222 (D. Del.) (previously reported Janssen Files First BPCIA Suit Over Simponi(R)(golimumab) Biosimilar).
三月 20, 2026阅读更多
新闻ImmunityBio, Inc. partners with Accord Healthcare, Ltd..To support this expansion, ImmunityBio Inc. (NASDAQ:IBRX) formed partnerships with Accord Healthcare in Europe and BioPharma & Cigalah in the Middle East, while establishing new subsidiaries in Dublin and Riyadh.
二月 25, 2026阅读更多
查看 Accord Healthcare 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
